This second edition of the “living paper” contributes to the global knowledge on how countries are responding to the pandemic by documenting real-time actions in a key area of response – that is, social protection measures planned or implemented by governments.
For the purpose of this revie...w, we organized interventions by social assistance, social insurance and labor market programs. For the latter measures, we deliberately focused on supply-side programs (e.g., mostly wage subsidies and other activation programs). In most cases, data sources include official information published in government websites, while in many cases we reported information from global and national news outlets. In some cases, information was provided directly by country-based experts, while the full database was validated and integrated by regional and country social protection teams at the World Bank. Overall, findings should be considered preliminary and interpreted with caution.
more
การแพร่ระบาด
อาการ
การป้องกัน
การรักษา
This compendium developed by UNICEF provides details of different handwashing station designs and estimated cost.
La evidencia disponible a nivel internacional sobre el uso de un segundo refuerzo muestra una mayor duración de la respuesta inmune y una disminución de la internación y la mortalidad por COVID 19 en la población de adultos mayores y huéspedes inmunocomprometidos. Por otra parte, el personal de... salud se beneficiaría considerando el mayor riesgo de exposición y la caída de la respuesta inmune con el tiempo. En base a lo señalado previamente se recomienda incorporar y
priorizar un segundo refuerzo al esquema de vacunación contra la COVID-19 del:
- Personal de salud independientemente de la edad
- Personas de 50 años o mayores
- Personas de 12 años o más con inmunocompromiso
A la vez, se progresará de manera escalonada y simultánea con la vacunación de segundo refuerzo del:
- Personal estratégico
- Personas de 18 a 49 años con factores de riesgo
Continuando en la estrategia de segundo refuerzo todas las personas a partir de los 18 años. Las personas gestantes con indicación de segundo refuerzo, se recomienda vacunas de plataforma de ARNm (Pfizer-BioNTech o Moderna)
more
Acessed on 15.08.2022
Recursos de información COVID-19 - Argentina - OPS/OMS | Organización Panamericana de la Salud
Website
The guidance provides critical considerations and practical checklists to keep schools safe. It also advises national and local authorities on how to adapt and implement emergency plans for educational facilities.
In the event of school closures, the guidance includes recommendations to mitigate... against the possible negative impacts on children’s learning and wellbeing. This means having solid plans in place to ensure the continuity of learning, including remote learning options such as online education strategies and radio broadcasts of academic content, and access to essential services for all children. These plans should also include necessary steps for the eventual safe reopening of schools.
Where schools remain open, and to make sure that children and their families remain protected and informed.
more
Эта Специальная Коллекция включает Кокрейновские обзоры по следующим темам: лекарственное лечение, поведенческая поддержка и постепенный отказ от курения. Вмеша...ельства, имитирующие акт курения, в частности, электронные сигареты, были исключены из этой коллекции, поскольку риски, связанные с их использованием в связи с текущей пандемией, не ясны. Кокрейновская группа по табачной зависимости работает над тем, чтобы вся соответствующая информация была актуальна (обновлена), чтобы обеспечить поддержку людям, пытающимся бросить курить в это трудное время.
more
La presente publicación describe un resumen de la evidencia científica disponible sobre el uso de Cloroquina e hidroxicloroquina, así como su profilaxis y tratamiento para COVID-19.
Esta publicación pertenece al compendio Publicaciones Minsa sobre COVID-19
Zarazne bolesti kao što je virus COVID-19 mogu poremetiti okruženje u kojem djeca rastu i razvijaju se. Remećenje u odnosu sa porodicom, prijateljima, svakodnevnim aktivnostima i široj zajednici može imati negativne posljedice na dobrobit, razvoj i zaštitu djece. Pored toga, mjere koje se pri...mjenjuju kako bi se spriječilo i suzbilo širenje virusa COVID-19 mogu djecu izložiti rizicima u pogledu njihove zaštite. Karantin i mjere izolacije u kućama, objektima i određenim zonama mogu imati negativan utjecaj na djecu i njihove porodice.
Cilj ovog dokumenta je da pruži podršku stručnjacima koji rade na polju zaštite djece kako bi na bolji način odgovorili na rizike za zaštitu djece za vrijeme pandemije virusa COVID-19. U prvom dijelu govori se o tome kakav rizik virus COVID-19 može predstavljati za djecu u smislu njihove zaštite. U drugom dijelu izložene su programske opcije u skladu s Minimalnim standardima za zaštitu djece u humanitarnim akcijama iz 2019. godine (CPMS) i Smjernicama: Zaštita djece za vrijeme epidemija zaraznih bolesti.
more
COVID-19 gibi bulaşıcı hastalıklar, çocukların büyüyüp geliştiği ortamlara zarar verebilir. Ailelerde, arkadaşlıklarda, günlük rutinlerde ve toplumda yaşanan aksamalar çocukların iyi olma hali, gelişimi ve korunması bakımından olumsuz sonuçlar doğurabilir. Ayrıca, COVID-19...un yayılmasını önlemek ve kontrol altına almak için uygulanan tedbirler, çocukları korumayla ilgili risklere maruz bırakabilir. Evlerde, kurum ve kuruluşlarda ve bölgelerde uygulanan karantina ve izolasyon tedbirlerinin çocuklar ve aileleri üzerinde olumsuz etkileri olabilir
Bu bilgilendirmenin amacı, COVID-19 pandemisi sırasında çocuk koruma risklerine daha iyi müdahale edebilmeleri için çocuk koruma uzmanlarına destek sunmaktır. 1. Bölümde COVID-19’un çocuklar açısından ortaya çıkmasına neden olabileceği olası çocuk koruma riskleri sunulmuştur. 2. Bölümde ise İnsani Yardım Hareketinde Çocuk Korumaya Yönelik Asgari Standartlar (2019) ile Kılavuz Notu: Bulaşıcı Hastalık Salgınları Sırasında Çocukların Korunması belgelerine uygun program seçenekleri sunulmuştur.
more
Q&A on COVID-19, HIV and antiretrovirals - Hỏi Đáp về COVID-19, HIV và thuốc antiretrovirals (ARVs)
La presente publicación describe la evidencia científica disponible sobre la efectividad del uso de mascarillas o respiradores en la prevención y control de infecciones respiratorias virales incluido COVID-19 a nivel comunitario y hospitalario. Se identificaron 778 estudios publicados hasta abril... de 2020 como parte de la búsqueda sistemática de evidencias (320 población general y 452 personal de salud). Siete estudios fueron seleccionados para responder a las preguntas de investigación de los cuales cinco fueron ensayos clínicos respecto al subgrupo de población general y una revisión sistemática y un ensayo clínico respecto al subgrupo de personal de salud.
Esta publicación pertenece al compendio Publicaciones Minsa sobre COVID-19
more
This statement is for healthcare professionals who are performing CPR in a healthcare setting.
Accessed: 26.03.2020
Тридцать первого декабря 2019 г. ВОЗ получила информацию о случаях пневмонии неясного происхождения (причина неизвестна), выявленных в г. Ухань китайско...й провинции Хубэй. Седьмого января китайские власти сообщили, что заболевание имеет вирусную природу и вызвано новым коронавирусом (2019-nCoV).
more
Overview
• How are diseases transmitted from person to person?
• What are the principles of infection prevention and control
• What IPC measures are other countries / organisations recommending for the transport industry/workers?
• How can we apply this knowledge to protect us while w...e protect our country?
• Administrative controls = screening and awareness, people flow, health promotion
• Environmental controls = ventilation, airflow
• Personal protective equipment = use of masks, gloves, hand hygiene
more
Interim guidance 19 March 2020